Rhythm Pharmaceuticals Logo

Rhythm Pharmaceuticals

🇺🇸
RYTM
US76243J1051

Rhythm Pharmaceuticals is a US-based biopharmaceutical company focused on developing and commercializing medicines for rare genetic diseases of obesity. The company is committed to advancing innovative therapies designed to improve the quality of life for patients worldwide affected by these conditions.

Next Quarterly Earnings

Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days

Stock Price

All Dates

Company Information

Name
Rhythm Pharmaceuticals
Ticker Symbol
RYTM
ISIN
US76243J1051
Country
🇺🇸
USA